NeuShen Therapeutics

Private

ShanghaiHealthcare & Life Scienceshttps://www.neushen.com/

Last Round

Series A

Extension

Jan 28, 2026

Total Funding Raised

$20M

Company Overview

NeuShen Therapeutics is a biotechnology company that develops innovative therapies for neurological and psychiatric disorders using AAV-based gene therapy and small molecule discovery platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologydrug discoveryCNS disordersneurodegenerative diseasessmall molecule inhibitorbiotech startupAI drug discoveryclinical-stage biotechpsychiatric conditionstarget identificationin silico drug discoverybiologic therapiespharma licensingcentral nervous systemdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuShen Therapeutics Comps

Public and private peers based on sector, stage, and business model.

NeuShen Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeuShen Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Jan 28, 2026
Series A	Apr 18, 2025
Pre Seed	Sep 29, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Joan Shen

Chief Executive Officer and Founder

Founding Team

NeuShen Therapeutics Investors

Notable investors and investment history

NeuShen Therapeutics investors
Investor	Rounds
Shanghai Healthcare Capital	Series A Extension, Series A
Lapam Capital	Series A Extension, Series A, Pre Seed
TTM Capital	Pre Seed, Series A Extension, Series A
Lilly Asia Ventures	Series A Extension
Pivotal bioVenture Partners	Series A Extension

View all Investors

NeuShen Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NeuShen Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuShen Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Employee Range12

Year Founded2021

Last FundingJan 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.